Ferroportin inhibition attenuates pulmonary hypertension in hypoxic sickle cell disease mice.

Saved in:
Bibliographic Details
Title: Ferroportin inhibition attenuates pulmonary hypertension in hypoxic sickle cell disease mice.
Authors: Lucero MJ; Translational Research Laboratory of Red Blood Cell Diseases and Hypoxia Related Illnesses, Cardiovascular Pulmonary Research Program, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Setua S; Center for Blood Oxygen Transport and Hemostasis, Department of Pediatrics, The University of Maryland School of Medicine, Baltimore, MD., Thangaraju K; Center for Blood Oxygen Transport and Hemostasis, Department of Pediatrics, The University of Maryland School of Medicine, Baltimore, MD., Khan A; Center for Blood Oxygen Transport and Hemostasis, Department of Pediatrics, The University of Maryland School of Medicine, Baltimore, MD., Lamb DR; Center for Blood Oxygen Transport and Hemostasis, Department of Pediatrics, The University of Maryland School of Medicine, Baltimore, MD., Lisk C; Translational Research Laboratory of Red Blood Cell Diseases and Hypoxia Related Illnesses, Cardiovascular Pulmonary Research Program, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Swindle D; Translational Research Laboratory of Red Blood Cell Diseases and Hypoxia Related Illnesses, Cardiovascular Pulmonary Research Program, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Cendali FI; Translational Research Laboratory of Red Blood Cell Diseases and Hypoxia Related Illnesses, Cardiovascular Pulmonary Research Program, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO., Dzieciatkowska M; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO., Stephenson D; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO., Pak DI; Translational Research Laboratory of Red Blood Cell Diseases and Hypoxia Related Illnesses, Cardiovascular Pulmonary Research Program, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Tolson R; Translational Research Laboratory of Red Blood Cell Diseases and Hypoxia Related Illnesses, Cardiovascular Pulmonary Research Program, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Zaeske S; Translational Research Laboratory of Red Blood Cell Diseases and Hypoxia Related Illnesses, Cardiovascular Pulmonary Research Program, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Rana NK; Translational Research Laboratory of Red Blood Cell Diseases and Hypoxia Related Illnesses, Cardiovascular Pulmonary Research Program, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Khan S; Translational Research Laboratory of Red Blood Cell Diseases and Hypoxia Related Illnesses, Cardiovascular Pulmonary Research Program, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Westover N; Translational Research Laboratory of Red Blood Cell Diseases and Hypoxia Related Illnesses, Cardiovascular Pulmonary Research Program, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Davizon-Castillo P; Bloodworks Northwest, University of Washington, Seattle Children's Hospital, Seattle, WA., George G; Division of Hematology, Colorado Sickle Cell Treatment and Research Center, University of Colorado School of Medicine, Aurora, CO., Hassell K; Division of Hematology, Colorado Sickle Cell Treatment and Research Center, University of Colorado School of Medicine, Aurora, CO., Nuss R; Division of Hematology, Colorado Sickle Cell Treatment and Research Center, University of Colorado School of Medicine, Aurora, CO., D'Alessandro A; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO., Manolova V; CSL Research, Schlieren, Switzerland., Irwin DC; Translational Research Laboratory of Red Blood Cell Diseases and Hypoxia Related Illnesses, Cardiovascular Pulmonary Research Program, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Buehler PW; Center for Blood Oxygen Transport and Hemostasis, Department of Pediatrics, The University of Maryland School of Medicine, Baltimore, MD.; Department of Pathology, The University of Maryland School of Medicine, Baltimore, MD.
Source: Blood advances [Blood Adv] 2026 May 12; Vol. 10 (9), pp. 3229-3242.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2025018680